Doctoral school within Synaptic Dysfunction in Alzheimer Disease (SyDAD)
The European Training Network (ETN) Synaptic Dysfunction in Alzheimer Disease (SyDAD) is an international doctoral school that starts in April 2016. 15 doctoral students will be admitted and have the opportunity to become Alzheimer researchers of tomorrow.
SyDAD is a European Training Network sponsored by Marie Sklodowska Curie Actions which will train 15 Early Stage Researchers (ESR´s, PhD students) and perform a collaborative research program to reveal the mechanisms behind synaptic dysfunction in Alzheimer Disease (AD).
For these purposes, we have collected world-leading expertise in AD research and synaptic biology from distinguished universities and academic institutes as well as pharmaceutical companies. The PhD students will have access to this expertise, cutting-edge technology, an excellent training programme and international exchanges.
SyDAD consists of four academic organisations and two pharmaceutical companies that all will hire PhD students.
Karolinska Institutet (coordinating university)
Prof Bengt Winblad
Project Manager and Site-responsible scientist
Assoc Prof Susanne Frykman
University of Bordeaux
Prof Christophe Mulle
University of Milano
Prof Monica di Luca
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
Juan D Pita-Almenar
In addition, collaborations, secondments and training will also take place at:
- Gothenburg University
- Astra Zeneca Translational Center
- AlzeCure Discovery
- Serendipity Innovations
- Alzheimer Europe
ESR projects and how to apply
The ESR´s will pursue 15 different PhD projects, distributed at the six participating organisations. The applicants are asked to send separate applications directly to each organisation and to provide a list which SyDAD projects (maximum three) they apply for in a prioritised order.
For more information on the ESR projects and how to apply, see SyDAD´s websait.
Professor Bengt Winblad
Phone: +46-8-585 854 74